Aubrai by Bio is projected to decline to $1.08 by 2027, a -21% move from its current price of $1.36. AUBRAI is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell. Market sentiment sits at 26/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 7/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.28 | $1.36 | $1.45 | -0.09% |
| Jul 14 | $1.24 | $1.36 | $1.48 | -0.18% |
| Jul 15 | $1.22 | $1.36 | $1.51 | -0.26% |
| Jul 16 | $1.20 | $1.36 | $1.54 | -0.35% |
| Jul 17 | $1.18 | $1.35 | $1.56 | -0.44% |
| Jul 18 | $1.16 | $1.35 | $1.58 | -0.53% |
| Jul 19 | $1.15 | $1.35 | $1.59 | -0.62% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.15 | $1.35 | $1.59 | -0.62% |
| Week 2 | $1.06 | $1.34 | $1.70 | -1.23% |
| Week 3 | $1.00 | $1.34 | $1.78 | -1.84% |
| Week 4 | $0.9538 | $1.33 | $1.85 | -2.44% |
| Week 5 | $0.9117 | $1.32 | $1.91 | -3.04% |
| Week 6 | $0.8747 | $1.31 | $1.96 | -3.64% |
| Week 7 | $0.8416 | $1.30 | $2.02 | -4.23% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Aubrai by Bio is described as the world’s first decentralized scientific agent with knowledge stemming from thousands of private lab notes, internal chats and unpublished insights from the lab of Dr. Aubrey de Grey and the collective intelligence of the global longevity community. Co-developed by VitaDAO and BIO, the first BioAgent is designed to fight the greatest killer of all time: Aging.
As an onchain AI co-scientist, Aubrai can generate and validate hypotheses, design wet-lab experiments and encrypt data when asked, enriching research outputs while protecting trade secrets. At the heart of Aubrai's mission lies the Robust Mouse Rejuvenation (RMR2) project – Aubrey's ambitious study to double the remaining lifespan of middle‑aged mice. If successful, it could be aging's "AlphaFold moment": a proof that multi‑target rejuvenation works and is worth scaling.
The current price of Aubrai by Bio is $1.36. It ranks 2223 by market capitalization, with a market cap of $1.94M. The price outlook shows a mixed path with a neutral near-term view and some years of potential upside later in the forecast.
In 2026, the average price is $1.36 with 0% ROI and Neutral sentiment, suggesting a holding pattern near the current level.
A major floor 55.2% below — a decisive break under it would weaken the trend.
The nearest floor, 12.5% below — buyers have tended to step in here.
The nearest ceiling, 28.3% above — a clean break opens room to run.
A major ceiling 172.7% above — clearing it would confirm fresh momentum.
Key AUBRAI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AUBRAI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.34 | Buy | $1.35 | Buy |
| MA 10 | $1.38 | Sell | $1.38 | Sell |
| MA 20 | $1.46 | Sell | $1.43 | Sell |
| MA 50 | $1.55 | Sell | $1.50 | Sell |
| MA 100 | $1.44 | Sell | $1.68 | Sell |
| MA 200 | $1.85 | Sell | $2.83 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.50 | Neutral |
| Stoch RSI (14) | 19.19 | Buy |
| CCI (20) | -75.10 | Neutral |
| Williams %R (14) | -88.30 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -22.15 | Sell |
| Bollinger %B (20,2) | 0.28 | Neutral |
| Stochastic %K (14) | 11.70 | Buy |
| TRIX (15) | -0.40 | Sell |
| Awesome (5,34) | -0.09 | Sell |
| Ultimate (7,14,28) | 39.84 | Neutral |
| Momentum (10) | -0.17 | Sell |
| Aroon Osc (25) | 52.00 | Buy |
| Hull MA (9) | 1.31 | Buy |
| ADX (14) | 11.73 | Neutral |
| ATR (14) | 0.07 | Info |
The 30-day technical picture is Bearish, with RSI(14) at 40. In terms of trend components, the SMA50 is $1.55 and the SMA200 is $1.85, indicating the near-term price remains below the longer-term average. There is support at $1.19 and resistance at $1.74, framing the immediate trading range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.5856 | $1.36 | $1.74 | 0% | Neutral | |
| $0.7547 | $1.08 | $1.67 | -21% | Bearish | |
| $0.6463 | $0.9918 | $1.65 | -27% | Bearish | |
| $0.4725 | $0.7724 | $1.35 | -43% | Bearish | |
| $0.9371 | $1.62 | $2.97 | +19% | Neutral | |
| $0.8388 | $1.54 | $2.92 | +13% | Neutral | |
| $0.466 | $0.8994 | $1.77 | -34% | Bearish | |
| $0.472 | $0.9591 | $1.94 | -29% | Bearish | |
| $0.8476 | $1.81 | $3.77 | +33% | Bullish | |
| $0.8148 | $1.81 | $3.86 | +33% | Bullish | |
| $0.8074 | $1.79 | $4.13 | +32% | Bullish | |
| $0.677 | $1.50 | $3.46 | +11% | Neutral |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.5856 | $1.36 | $1.88 | +0.00% |
| August 2026 | $1.18 | $1.45 | $1.87 | +6.40% |
| September 2026 | $1.00 | $1.25 | $1.65 | -13.29% |
| October 2026 | $0.9977 | $1.26 | $1.70 | +0.65% |
| November 2026 | $1.05 | $1.35 | $1.84 | +6.74% |
| December 2026 | $0.9684 | $1.25 | $1.74 | -6.96% |
Click any year to see its month-by-month AUBRAI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Aubrai by Bio's 2026 outlook centres on $1.36, within a $0.5856 to $1.74 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, AUBRAI could reach as high as $1.67, with a base case around $1.08 and support toward $0.7547 — roughly -21% from $1.36. A cyclical pullback looks likely — prices rarely move in a straight line.
Expect AUBRAI to range from $0.6463 to $1.65 through 2028. The $0.9918 average target implies a -27% move from current prices. That is -8% versus the projected 2027 average. Expect choppier, lower action through this leg of the cycle.
The AUBRAI price prediction for 2029 points to an average of $0.7724 (low $0.4725, high $1.35) — a potential decline of -43% on today's $1.36. A cyclical pullback looks likely — prices rarely move in a straight line.
In 2030, AUBRAI is projected to trade between $0.9371 and $2.97, averaging $1.62 — a potential gain of +19% from today's $1.36. That is up +110% on the projected 2029 average. A consolidation phase looks the most probable path here.
Aubrai by Bio's 2031 outlook centres on $1.54, within a $0.8388 to $2.92 range. That is -5% versus the projected 2030 average. That marks a +13% change versus current levels. Price action looks broadly range-bound.
By 2032, AUBRAI could reach as high as $1.77, with a base case around $0.8994 and support toward $0.466 — roughly -34% from $1.36. Expect choppier, lower action through this leg of the cycle.
Expect AUBRAI to range from $0.472 to $1.94 through 2033. The $0.9591 average target implies a -29% move from current prices. That is up +7% on the projected 2032 average. A cyclical pullback looks likely — prices rarely move in a straight line.
The AUBRAI price prediction for 2034 points to an average of $1.81 (low $0.8476, high $3.77) — a potential gain of +33% on today's $1.36. Buyers look set to stay in control over this stretch.
In 2035, AUBRAI is projected to trade between $0.8148 and $3.86, averaging $1.81 — a potential gain of +33% from today's $1.36. That is 0% versus the projected 2034 average. Momentum favours further upside here.
Aubrai by Bio's 2040 outlook centres on $1.79, within a $0.8074 to $4.13 range. That is -1% versus the projected 2035 average. That marks a +32% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, AUBRAI could reach as high as $3.46, with a base case around $1.50 and support toward $0.677 — roughly +11% from $1.36. Price action looks broadly range-bound.
Investing $1,000 in AUBRAI today (≈ 735.294118 AUBRAI) could be worth
$1,106.23
+$106.23 (+11%) by 2050 · US Dollar
Based on the average projected AUBRAI price of $1.5 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AUBRAIwould be worth at today's price.
$1,000 invested in AUBRAI on Aug 28, 2025 (≈ 91.013565 AUBRAI) would be worth
$123.78
-$876.22 (-87.6%) today · 0.12× · US Dollar
Based on a AUBRAI entry price of $10.99 vs. today's $1.36.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.43 | $949.25 | -5.1% |
| 1 month ago | $1.39 | $976.54 | -2.3% |
| 3 months ago | $0.63273 | $2,149.42 | +114.9% |
| 6 months ago | $3.46 | $393.11 | -60.7% |
| All time ago | $10.99 | $123.78 | -87.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AUBRAI forecast.
$2.70 is within our bullish range by 2030, but above the base case.
Implied market cap at $2.70: $3.86M
The multi-year projections show a varied path. For 2026 the average price is $1.36 with 0% ROI and Neutral sentiment, followed by 2027 with an average of $1.08 and -20.8% ROI and Bearish sentiment, and 2028 with an average of $0.9918 and -27.1% ROI. In 2029 the average is $0.7724 with -43.2% ROI.
The forecast turns more constructive in 2030, with an average of $1.62 and 19.4% ROI in Neutral sentiment, and in 2031 an average of $1.54 with 12.9% ROI. The years 2034 and 2035 show bullish momentum, with averages of $1.81 and $1.81 and ROIs of 33.3% and 33.1%, respectively. By 2040 the average is $1.79 with a 31.9% ROI and bullish sentiment, and by 2050 the average is $1.50 with 10.6% ROI and Neutral sentiment.
Tap a question to reveal the answer.
In 2030 the forecast lists a min of $0.9371, an average of $1.62 and a max of $2.97, with a 19.4% ROI and Neutral sentiment.
Forecasts show a mix of outcomes: some years with negative ROI (e.g., 2027 -20.8%, 2028 -27.1%, 2029 -43.2%), and later years with positive upside (2030 19.4%, 2034 33.3%, 2035 33.1%, 2040 31.9%, 2050 10.6%). These are estimates and not guarantees.
Yes. The forecast maximum in 2040 is $4.13, indicating a possible peak around that level per the projections.
Bearish sentiment with RSI(14) at 40. The SMA50 is $1.55 and the SMA200 is $1.85, with a support of $1.19 and a resistance of $1.74. The 30-day range spans $0.9664 to $1.91.
All-time high is $27.72 and all-time low is $0.5207.
Aubrai by Bio Community Discussion
0Share your Aubrai by Bio price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.